Investors were hoping that a recent wave of new listings would reignite the IPO market after a near 18-month dry spell, but stocks including chip designer Arm and RayzeBio have slipped from their debut highs amid persistent worries about high interest rates and inflation.
Investors were hoping that a recent wave of new listings would reignite the IPO market after a near 18-month dry spell, but stocks including chip designer Arm and RayzeBio have slipped from their debut highs amid persistent worries about high interest rates and inflation. Investors were hoping that a recent wave of new listings would reignite the IPO market after a near 18-month dry spell, but stocks including chip designer Arm and RayzeBio have slipped from their debut highs amid persistent worries about high interest rates and inflation. Moneycontrol Latest News Read More
English 
हिन्दी